Targeting Pan-Cancer Stemness: Core Regulatory lncRNAs as Novel Therapeutic Vulnerabilities
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311684 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Shengcheng Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Gene Function and Regulation and Guangzhou Key Laboratory of Healthy Aging Research, School of Life Sciences, Sun Yat-sen Unive…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplastic Stem Cells, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Integrated Project of Major Research Plan of National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor stemness represents a key biological process that drives tumor progression and therapeutic resistance across various cancer types. To systematically elucidate the regulatory roles of long non-coding RNAs (lncRNAs) in this process, we integrated bulk transcriptomic data from The Cancer Genome Atlas (TCGA) with publicly available pan-cancer single-cell transcriptomic atlases. Using machine-learning-based stemness metrics, we successfully quantified stemness features and identified unique lncRNA gene sets for each cancer type at the bulk data level. The high-stemness subtype exhibited enhanced proliferation, an immunosuppressive microenvironment, and profound metabolic reprogramming. Based on these findings, we constructed a robust prognostic model with remarkable predictive performance across multiple cancer types. At the single-cell resolution, we reconstructed the dynamic trajectory of stemness evolution, uncovering distinctive metabolic and cell-communication patterns within cancer stem cells (CSCs). This multi-scale analysis consistently nominated a core set of regulatory lncRNAs, including NEAT1 and MALAT1. Our work not only nominates potential targets for stemness-directed therapy but also provides a comprehensive framework for understanding lncRNA-driven mechanisms of cancer aggressiveness and resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Gene Function and Regulation and Guangzhou Key Laboratory of Healthy Aging Research, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.
ORCID-Profile: Shengcheng Deng, Yufan Yang, Yuanyan Xiong
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Integrated Project of Major Research Plan of National Natural Science Foundation of China
Zitieren
APA
Deng, S., Yang, Y., Gao, D., Gao, J., & Xiong, Y. (2025). Targeting Pan-Cancer Stemness: Core Regulatory lncRNAs as Novel Therapeutic Vulnerabilities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311684
Vancouver
Deng S, Yang Y, Gao D, Gao J, Xiong Y. Targeting Pan-Cancer Stemness: Core Regulatory lncRNAs as Novel Therapeutic Vulnerabilities. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311684
BibTeX
@article{Deng2025,
author = {Deng, Shengcheng and Yang, Yufan and Gao, Dapeng and Gao, Jiajun and Xiong, Yuanyan},
title = {Targeting Pan-Cancer Stemness: Core Regulatory lncRNAs as Novel Therapeutic Vulnerabilities},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311684}
}
EUVIMED